Rajesh Kumar
Stock Analyst at HSBC
(3.23)
# 959
Out of 4,884 analysts
21
Total ratings
60%
Success rate
12.99%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Downgrades: Reduce | $1,150 → $700 | $780.67 | -10.33% | 2 | Apr 28, 2025 | |
| IQV IQVIA Holdings | Downgrades: Hold | $260 → $160 | $164.24 | -2.58% | 1 | Apr 25, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $33.79 | +24.30% | 1 | Apr 25, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $185 | $189.28 | -2.26% | 3 | Jun 5, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $429.33 | +56.06% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $203.20 | +37.80% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $308.55 | +49.08% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $17.01 | -23.57% | 1 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $46.92 | +12.96% | 2 | Oct 27, 2023 | |
| MRNA Moderna | Initiates: Reduce | $97 | $30.49 | +218.14% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $110.00 | +12.73% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $25.38 | +97.01% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $80.93 | +51.98% | 1 | Jul 14, 2023 |
Eli Lilly and Company
Apr 28, 2025
Downgrades: Reduce
Price Target: $1,150 → $700
Current: $780.67
Upside: -10.33%
IQVIA Holdings
Apr 25, 2025
Downgrades: Hold
Price Target: $260 → $160
Current: $164.24
Upside: -2.58%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $33.79
Upside: +24.30%
AbbVie
Jun 5, 2024
Upgrades: Buy
Price Target: $185
Current: $189.28
Upside: -2.26%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $429.33
Upside: +56.06%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $203.20
Upside: +37.80%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $308.55
Upside: +49.08%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $17.01
Upside: -23.57%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $46.92
Upside: +12.96%
Moderna
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $30.49
Upside: +218.14%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $110.00
Upside: +12.73%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $25.38
Upside: +97.01%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $80.93
Upside: +51.98%